CytoSorbents receives FDA appeal hearing date for DrugSorb-ATR device

6 days ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. CytoSorbents receives FDA appeal hearing date for DrugSorb-ATR device

Related

Pfizer corporate affairs chief to depart after 18-year tenure

Pfizer corporate affairs chief to depart after 18-year tenur...

9 minutes ago 0
Bill Gates gave so much money away that $51 billion just got swiped from his net worth—now his former assistant is wealthier than him

Bill Gates gave so much money away that $51 billion just got...

9 minutes ago 0
McDonald’s launches three new spicy breakfast menu items that are only available for a limited time

McDonald’s launches three new spicy breakfast menu items tha...

21 minutes ago 0
WisdomTree launches ETF targeting winners of geopolitical, macro shifts

WisdomTree launches ETF targeting winners of geopolitical, m...

24 minutes ago 0
Meet the ex-Amazon exec who pitched Prime Day to Jeff Bezos—and turned the slowest shopping season into a $14.2 billion sales empire

Meet the ex-Amazon exec who pitched Prime Day to Jeff Bezos—...

26 minutes ago 0
No more extension to August 1 deadline for reciprocal tariff, Trump says

No more extension to August 1 deadline for reciprocal tariff...

33 minutes ago 0
X raises censorship concerns in India after receiving orders to block Reuters' accounts

X raises censorship concerns in India after receiving orders...

36 minutes ago 0
A.O. Smith poised for stronger Q2 as China water-heater market outpaces forecast: UBS

A.O. Smith poised for stronger Q2 as China water-heater mark...

37 minutes ago 0
United Airlines resumes flights to Tel Aviv

United Airlines resumes flights to Tel Aviv

39 minutes ago 0
Mali plans to sell gold reserves at Barrick complex to fund operations - Reuters

Mali plans to sell gold reserves at Barrick complex to fund ...

40 minutes ago 0
SoundHound, BigBear.ai surge as agentic AI names rally

SoundHound, BigBear.ai surge as agentic AI names rally

41 minutes ago 0
Tesla bull Dan Ives says the company has reached a ‘tipping point’ and lays out a 3-point plan for the board to rein in Elon Musk

Tesla bull Dan Ives says the company has reached a ‘tipping ...

41 minutes ago 0
Elon Musk calls the U.S. dollar ‘hopeless,’ says his America Party will embrace Bitcoin

Elon Musk calls the U.S. dollar ‘hopeless,’ says his America...

41 minutes ago 0
Novo Nordisk submits new Wegovy dose for EU approval

Novo Nordisk submits new Wegovy dose for EU approval

45 minutes ago 0
Users accuse Elon Musk’s Grok of a rightward tilt after xAI changes its internal instructions to assume viewpoints from the media are ‘biased’

Users accuse Elon Musk’s Grok of a rightward tilt after xAI ...

49 minutes ago 0
Tesla sold precisely zero cars in Turkey in January—now it’s Elon Musk’s hottest market. Here’s why

Tesla sold precisely zero cars in Turkey in January—now it’s...

52 minutes ago 0
National Vision gains as Barclays upgrades stock to Overweight

National Vision gains as Barclays upgrades stock to Overweig...

53 minutes ago 0
Vertiv upgraded at Melius on increased AI spending

Vertiv upgraded at Melius on increased AI spending

57 minutes ago 0
Ford's Michigan EV battery plant still eligible for federal tax credits

Ford's Michigan EV battery plant still eligible for federal ...

1 hour ago 0
18 REITs estimated to raise dividends in Q3, RLJ Lodging Trust expected to lead - report

18 REITs estimated to raise dividends in Q3, RLJ Lodging Tru...

1 hour ago 0

Trending

1. xi jinping
2. amanda anisimova
3. federal bank
4. supriya shrinate
5. sony sab
6. shamim hossain
7. pulse
8. wimbledon live
9. surya sethupathi
10. hssc cet exam date 2025

Popular

TechCrunch Mobility: The state of EV sales and Rivian secures the next $1B from VW

TechCrunch Mobility: The state of EV sales and Rivian secure...

3 days ago 7
Home Depot is buying GMS for about $4.3 billion as retailer chases more home pros

Home Depot is buying GMS for about $4.3 billion as retailer ...

1 week ago 7
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved